W. Barsan

Central versus peripheral intravenous routes in cardiopulmonary resuscitation.

J. Hedges, W. Dalsey, S. Joyce, 1984, The American journal of emergency medicine.

Efficacy of levetiracetam, fosphenytoin, and valproate for established status epilepticus by age group (ESETT): a double-blind, responsive-adaptive, randomised controlled trial

Lisa H. Merck, Noelle K. Herzog, J. Ornato, 2020, The Lancet.

Statistical assessment of the prognostic and the predictive value of biomarkers-A biomarker assessment framework with applications to traumatic brain injury biomarker studies

R. Silbergleit, J. Tsimikas, B. Gajewski, 2022, Research methods in medicine & health sciences.

Early Convalescent Plasma for High-Risk Outpatients with Covid-19

D. Beiser, K. Schulman, R. Silbergleit, 2021, The New England journal of medicine.

Intramuscular versus intravenous therapy for prehospital status epilepticus.

R. Conwit, R. Silbergleit, D. Lowenstein, 2012, New England Journal of Medicine.

Randomized Trial of Three Anticonvulsant Medications for Status Epilepticus.

Nathan Fountain, Caitlyn Meinzer, Shlomo Shinnar, 2019, The New England journal of medicine.

Brain Oxygen Optimization in Severe Traumatic Brain Injury (BOOST-3): a multicentre, randomised, blinded-endpoint, comparative effectiveness study of brain tissue oxygen and intracranial pressure monitoring versus intracranial pressure alone

Lisa H. Merck, L. Shutter, R. Diaz-Arrastia, 2022, BMJ Open.

COVID-19 convalescent plasma boosts early antibody titer and does not influence the adaptive immune response

D. Dimitrov, R. Silbergleit, S. Yeatts, 2023, JCI insight.

Intramuscular versus intravenous therapy for prehospital status epilepticus.

R. Conwit, R. Silbergleit, D. Lowenstein, 2012, The New England journal of medicine.